Satoshi Toki

828 total citations
55 papers, 697 citations indexed

About

Satoshi Toki is a scholar working on Pharmacology, Molecular Biology and Biochemistry. According to data from OpenAlex, Satoshi Toki has authored 55 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 14 papers in Molecular Biology and 14 papers in Biochemistry. Recurrent topics in Satoshi Toki's work include Aldose Reductase and Taurine (13 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Eicosanoids and Hypertension Pharmacology (9 papers). Satoshi Toki is often cited by papers focused on Aldose Reductase and Taurine (13 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Eicosanoids and Hypertension Pharmacology (9 papers). Satoshi Toki collaborates with scholars based in Japan. Satoshi Toki's co-authors include Takashi Ishida, Saki Yamano, Yoshito Kumagai, Tadao Terao, T Muto, Kazuma Ogawa, Yuko Ohno, Hisao Tsukamoto, Tomoko Hirohashi and Takahisa Sawada and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Satoshi Toki

55 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Toki Japan 15 224 186 148 134 112 55 697
Marjorie G. Horning United States 13 83 0.4× 324 1.7× 36 0.2× 27 0.2× 75 0.7× 22 745
Clarke Davison United States 11 291 1.3× 239 1.3× 16 0.1× 28 0.2× 44 0.4× 19 908
Shigeharu Tanayama Japan 15 101 0.5× 374 2.0× 31 0.2× 34 0.3× 20 0.2× 58 730
Tai Matsuzawa Japan 10 165 0.7× 223 1.2× 26 0.2× 23 0.2× 23 0.2× 19 809
Hideyo Noguchi Japan 17 128 0.6× 190 1.0× 28 0.2× 37 0.3× 13 0.1× 55 774
Arthur D. Hartman United States 15 66 0.3× 199 1.1× 12 0.1× 200 1.5× 50 0.4× 31 805
Joseph M. Machinist United States 17 267 1.2× 378 2.0× 16 0.1× 33 0.2× 53 0.5× 31 942
Kathryn T. Knecht United States 17 102 0.5× 193 1.0× 16 0.1× 173 1.3× 29 0.3× 28 877
Mika Kurihara Japan 20 428 1.9× 129 0.7× 110 0.7× 64 0.5× 13 0.1× 38 1.2k
David R. Dutton United States 10 387 1.7× 144 0.8× 49 0.3× 32 0.2× 11 0.1× 11 925

Countries citing papers authored by Satoshi Toki

Since Specialization
Citations

This map shows the geographic impact of Satoshi Toki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Toki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Toki more than expected).

Fields of papers citing papers by Satoshi Toki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Toki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Toki. The network helps show where Satoshi Toki may publish in the future.

Co-authorship network of co-authors of Satoshi Toki

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Toki. A scholar is included among the top collaborators of Satoshi Toki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Toki. Satoshi Toki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nomura, Yoshiko, et al.. (2001). Cloning and expression of cDNA encoding hamster liver 3-hydroxyhexobarbital/17β(3α)-hydroxysteroid dehydrogenase 1. Chemico-Biological Interactions. 130-132(1-3). 863–870. 3 indexed citations
2.
Yamano, Shigeru, et al.. (1999). Purification and Characterization of Two Major Forms of Naloxone Reductase from Rabbit Liver Cytosol, New Members of Aldo-Keto Reductase Superfamily.. Biological and Pharmaceutical Bulletin. 22(10). 1038–1046. 10 indexed citations
3.
Yamano, Saki, et al.. (1999). Purification and characterization of rat liver naloxone reductase that is identical to 3alpha-hydroxysteroid dehydrogenase. Xenobiotica. 29(9). 917–930. 6 indexed citations
4.
Ishida, Takayuki, et al.. (1998). In Vivo Formation of Codeinone-Glutathione Adduct: Isolation and Identification of a New Metabolite in the Bile of Codeine-Treated Guinea Pig. Journal of Analytical Toxicology. 22(7). 567–572. 6 indexed citations
5.
Yamano, Shigeru, Kenichi Ito, Shigenori Ogata, & Satoshi Toki. (1997). Purification, Characterization and Partial Primary Structure of Morphine 6-Dehydrogenase from Rabbit Liver Cytosol. Archives of Biochemistry and Biophysics. 341(1). 81–88. 9 indexed citations
7.
Toki, Satoshi, et al.. (1992). A NEW METABOLIC PATHWAY OF HEXOBARBITAL : PARTICIPATION OF GLUTATHIONE. Journal of Pharmacobio-Dynamics. 15(2). 1 indexed citations
8.
Kumagai, Yoshito, et al.. (1992). Hydroxyl radical-mediated conversion of morphine to morphinone. Xenobiotica. 22(5). 507–513. 6 indexed citations
9.
Kumagai, Yoshito, et al.. (1990). Stimulation mechanism of guinea pig liver-mediated reduction of naloxone by morphine.. Drug Metabolism and Disposition. 18(4). 462–466. 3 indexed citations
10.
Ishida, Takashi, Yoshito Kumagai, Yoshito Ikeda, et al.. (1989). (8S)-(glutathion-S-yl)dihydromorphinone, a novel metabolite of morphine from guinea pig bile.. Drug Metabolism and Disposition. 17(1). 77–81. 16 indexed citations
11.
Kumagai, Yoshito, Takashi Ishida, & Satoshi Toki. (1987). Method for determination of morphinone in urine and bile of guinea pig by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 421(1). 155–160. 16 indexed citations
12.
Yamano, Shigeru, et al.. (1986). Guinea-pig liver morphine 6-dehydrogenase as a naloxone reductase. Biochemical Pharmacology. 35(23). 4321–4326. 8 indexed citations
13.
Toki, Satoshi, et al.. (1985). PURIFICAITON AND PROPERTIES OF RAT LIVER 3-HYDROXYHEXOBARBITAL DEHYDROGENASE. Journal of Pharmacobio-Dynamics. 8(6). 1 indexed citations
14.
Ishida, Takayuki, et al.. (1983). TOXICITY OF MORPHINONE AND EFFECTS OF MORPHINONE ON THE ANALGESIC ACTIVITY OF MORPHINE. Journal of Pharmacobio-Dynamics. 6(4). 1 indexed citations
15.
Kido, Yasumasa, et al.. (1982). Effect of morphinone on opiate receptor binding and morphine-elicited analgesia. Life Sciences. 31(14). 1451–1457. 19 indexed citations
16.
Kido, Yasumasa, et al.. (1981). METABOLISM AND TOXICITY OF MORPHINE RELATED COMPOUNDS. Journal of Pharmacobio-Dynamics. 4(2). 1 indexed citations
17.
Toki, Satoshi, et al.. (1980). Preparation of four optical isomers of hydroxylated hexobarbital and activities of 3-hydroxyhexobarbital dehydrogenase from guinea pig and rabbit liver.. Drug Metabolism and Disposition. 8(2). 111–114. 3 indexed citations
18.
Toki, Satoshi, et al.. (1977). Dehydrogenation of Indanol by Rabbit Liver 3-Hydroxyhexobarbital Dehydrogenase. Xenobiotica. 7(6). 383–391. 5 indexed citations
20.
Tsukamoto, Hisao, Hidetoshi Yoshimura, & Satoshi Toki. (1955). Metabolism of Drugs. II. THe Metabolic Fate of Ethylhexabital (5-Cyclohexenyl-5-ethylbarbituric Acid). (2). Pharmaceutical Bulletin. 3(4). 239–242. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026